Connie Tong

Patent Agent
Full contact info


Neurocrine Partners With Takeda to Address Psychiatric Disorders

June 30, 2020

Cooley advised Neurocrine Biosciences on its strategic partnership agreement with Takeda to develop and commercialize potential therapies in Takeda’s early- to mid-stage pipeline for psychiatric disorders. The partnership will enhance Neurocrine’s growing pipeline of treatments and strengthen the company’s position as a leading neuroscience-focused biopharmaceutical company.

Neurocrine will develop and commercialize all pipeline compounds included in the collaboration. Under the terms of the agreement, Neurocrine will pay Takeda $120 million in upfront cash and up to $495 million in development milestones, $1.4 billion in commercial milestones and double-digit royalties on net sales.

Read more

Related contacts

Rena Kaminsky
Special Counsel, Palo Alto
Megan Browdie
Partner, Washington, DC
Jason Kent
Partner, New York
Carlos Ramirez
Partner, San Diego
Mika Reiner Mayer
Partner, Palo Alto
Kimberly Bolin
Patent Agent, Palo Alto
Connie Tong
Patent Agent, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Admissions and credentials

US Patent and Trademark Office